There have been previous reports of an increased thyroid cancer risk with GLP1-RAs although a recent study published in the journal, Thyroid , provide some reassurance
The SURMOUNT clinical program demonstrated substantial weight reductions establishing tirzepatide as one of the most effective obesity medications available
Always consult a licensed healthcare professional before beginning any wellness program.
Everything you need is included: syringes, alcohol wipes, and detailed instructions
Danuglipron made it further to Phase IIb, but Pfizer ended the entire program in April 2025 after a single asymptomatic case of potential drug-induced liver injury and dropped its third oral candidate a few months later
After one month of the hormone treatment, GE2-treated subjects of both sexes lost significantly more weight their vehicle-treated counterparts (Treatment and diet interaction: F( 1,47 ) = 9.936, p 2 = 0.175, p = 0.003